IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 79,029,194
- Share change
- +12,990,834
- Total reported value
- $3,467,731,111
- Put/Call ratio
- 29%
- Price per share
- $43.88
- Number of holders
- 202
- Value change
- +$578,501,456
- Number of buys
- 134
- Number of sells
- 62
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
6.2%
|
5,436,668
|
$193,436,647 | — | 31 Dec 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
4.4%
|
3,883,775
|
$138,184,715 | — | 31 Dec 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.1%
|
3,566,278
|
$126,889,000 | — | 31 Dec 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4%
|
3,551,891
|
$126,384,060 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4%
|
3,475,772
|
$123,667,968 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
2,991,899
|
$106,451,766 | — | 31 Dec 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.3%
|
2,925,094
|
$104,074,845 | — | 31 Dec 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
3%
|
2,630,292
|
$93,585,789 | — | 31 Dec 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
2.5%
|
2,202,812
|
$78,376,051 | — | 31 Dec 2023 | |
| Capital Research Global Investors |
13F
|
Company |
2.3%
|
1,976,870
|
$70,337,035 | — | 31 Dec 2023 | |
| Logos Global Management LP |
13F
|
Company |
2%
|
1,800,000
|
$64,044,000 | — | 31 Dec 2023 | |
| BVF INC/IL |
13F
|
Company |
2%
|
1,729,043
|
$61,519,350 | — | 31 Dec 2023 | |
| Holocene Advisors, LP |
13F
|
Company |
1.9%
|
1,700,135
|
$60,490,803 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.9%
|
1,643,293
|
$58,468,365 | — | 31 Dec 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
1.7%
|
1,520,000
|
$54,081,600 | — | 31 Dec 2023 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.7%
|
1,458,881
|
$51,906,986 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,351,337
|
$48,086,734 | — | 31 Dec 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.5%
|
1,286,300
|
$45,767,157 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
1,233,271
|
$43,879,781 | — | 31 Dec 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.2%
|
1,062,123
|
$37,790,336 | — | 31 Dec 2023 | |
| Redmile Group, LLC |
13F
|
Company |
1.1%
|
935,863
|
$33,298,006 | — | 31 Dec 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
912,786
|
$32,476,926 | — | 31 Dec 2023 | |
| FMR LLC |
13F
|
Company |
1%
|
888,209
|
$31,602,492 | — | 31 Dec 2023 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1%
|
875,747
|
$31,159,078 | — | 31 Dec 2023 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.75%
|
662,343
|
$23,566,164 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
611,009
|
$21,739,700 | — | 31 Dec 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.64%
|
564,700
|
$20,092,026 | — | 31 Dec 2023 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.61%
|
539,676
|
$19,201,670 | — | 31 Dec 2023 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.61%
|
531,967
|
$18,927,386 | — | 31 Dec 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.6%
|
529,506
|
$18,839,823 | — | 31 Dec 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.59%
|
516,341
|
$18,371,413 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.57%
|
496,456
|
$17,663,904 | — | 31 Dec 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.56%
|
490,039
|
$17,435,588 | — | 31 Dec 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.53%
|
466,271
|
$16,589,922 | — | 31 Dec 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.51%
|
450,000
|
$16,011,000 | — | 31 Dec 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.47%
|
414,059
|
$14,732,219 | — | 31 Dec 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.45%
|
395,019
|
$14,055,412 | — | 31 Dec 2023 | |
| First Turn Management, LLC |
13F
|
Company |
0.44%
|
382,382
|
$13,605,152 | — | 31 Dec 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.43%
|
378,913
|
$13,481,724 | — | 31 Dec 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.39%
|
346,490
|
$12,328,114 | — | 31 Dec 2023 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.39%
|
345,674
|
$12,299,081 | — | 31 Dec 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
335,000
|
$11,919,300 | — | 31 Dec 2023 | |
| Opaleye Management Inc. |
13F
|
Company |
0.35%
|
311,500
|
$11,083,170 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.32%
|
278,166
|
$9,897,146 | — | 31 Dec 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.31%
|
274,101
|
$9,752,515 | — | 31 Dec 2023 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.29%
|
251,295
|
$8,941,076 | — | 31 Dec 2023 | |
| AXA S.A. |
13F
|
Company |
0.28%
|
243,280
|
$8,655,902 | — | 31 Dec 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.26%
|
224,141
|
$7,974,937 | — | 31 Dec 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.25%
|
219,957
|
$7,826,070 | — | 31 Dec 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.25%
|
217,728
|
$7,746,762 | — | 31 Dec 2023 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q1 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.